Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Introduction of Differential KIR Activation Mediated Patters of NK Cell Cytotoxicity Against Myeloma

Thomas StÜbig, York Hildebrand, Karla Jungk, Aga Konielsk, Lars Lange, Thomas Binder, Heidi Duske, Djordje Atanackovic, Boris Fehse, Thomas Eiermann, Axel R. Zander, MD, Nicolaus Kröger, MD

Blood (2010) 116 (21): 5178.

https://doi.org/10.1182/blood.V116.21.5178.5178

Published: 2010

Journal Articles

Donor KIR-Haplotype B Improved Relapse-Free Survival After Allogeneic Stem Cell Transplantation for Multiple Myeloma

Nicolaus Kröger, Heidi Duske, Tatjana Zabelina, Thomas Binder, Boris Fehse, Orhan Sezer, MD, PhD, Thomas Stübig, York Hildebrandt, Djordje Atanackovic, Axel R. Zander, MD, Thomas Eiermann

Blood (2010) 116 (21): 2373.

https://doi.org/10.1182/blood.V116.21.2373.2373

Published: 2010

Journal Articles

Comparable Results of HLA-Mismatched Vs HLA-Matched Unrelated Donors for Allogeneic Stem Cell Transplantation Using Pre-Transplant ATG.

Nicolaus Kroeger, Tatjana Zabelina, Thomas Binder, Francis Ayuk, Ulrike Bacher, Gitta Amtsfeld, Alexander Muth, Heinrich Lellek, Rudolf Erttmann, Christine Wolschke, Thomas Eiermann, Axel R. Zander

Blood (2008) 112 (11): 966.

https://doi.org/10.1182/blood.V112.11.966.966

Published: 2008

Journal Articles

Donor KIR Haplotype Genes Significantly Influence Disease-Free and Overall Survival after Myeloablative Conditioning Followed by In Vivo T-Cell Depleted [ATG] Unrelated Stem Cell Transplantation.

Nicolaus Kroeger, MD, Thomas Binder, MD, PhD, Heike Schieder, MD, Helmut Renges, MD, Francis Ayuk, MD, Christine Wolschke, MD, Thomas H. Eiermann, MD, PhD, Axel Zander, MD

Blood (2005) 106 (11): 2040.

https://doi.org/10.1182/blood.V106.11.2040.2040

Published: 2005

Journal Articles

MTHFR-A1298C Polymorphism Is Associated with Veno-Occlusive Disease (VOD) and Liver Toxicity after Busulfan/Cyclophosphamide Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Eray Goekkurt, MD, Jan Stoehlmacher, MD, Christian Stueber, Christine Wolschke, MD, Tatjana Zabelina, MD, Thomas Eiermann, MD, Thomas Binder, MD, Simona Iacobelli, Axel R. Zander, MD, Nicolaus Kröger, MD

Blood (2005) 106 (11): 2730.

https://doi.org/10.1182/blood.V106.11.2730.2730

Published: 2005

Journal Articles

Comparison between Anti-Thymocyte Globulin and Alemtuzumab and the Possible Impact of KIR-Ligand Mismatch in Melphalan/Fludarabine Dose-Reduced Conditioning Followed by HLA-Matched and Mismatched Unrelated Stem Cell Transplantation in Patients with Multiple Myeloma.

Nicolaus Kroeger, MD, Brownen Shaw, MD, Simona Iacobelli, PhD, Tatjana Zabelina, MD, Karl Peggs, MD, Avichai Shimoni, MD, Arnon Nagler, MD, Thomas Binder, MD, PhD, Rainer Schwerdtfeger, MD, Michael Kiehl, MD, Herbert G. Sayer, MD, Francis Ayuk, MD, Thomas Eiermann, MD, PhD, David Marks, MD

Blood (2004) 104 (11): 980.

https://doi.org/10.1182/blood.V104.11.980.980

Published: 2004

Journal Articles

Kinetics of the Graft-Versus-Leukemia Response After Donor Leukocyte Infusions for Relapsed Chronic Myeloid Leukemia After Allogeneic Bone Marrow Transplantation

Herrad Baurmann, Stefan Nagel, Thomas Binder, Andreas Neubauer, Wolfgang Siegert, Dieter Huhn

Blood (1998) 92 (10): 3582–3590.

https://doi.org/10.1182/blood.V92.10.3582

Published: 1998

NARROW

Introduction of Differential KIR Activation Mediated Patters of NK Cell Cytotoxicity Against Myeloma

Donor KIR-Haplotype B Improved Relapse-Free Survival After Allogeneic Stem Cell Transplantation for Multiple Myeloma

Comparable Results of HLA-Mismatched Vs HLA-Matched Unrelated Donors for Allogeneic Stem Cell Transplantation Using Pre-Transplant ATG.

Donor KIR Haplotype Genes Significantly Influence Disease-Free and Overall Survival after Myeloablative Conditioning Followed by In Vivo T-Cell Depleted [ATG] Unrelated Stem Cell Transplantation.

MTHFR-A1298C Polymorphism Is Associated with Veno-Occlusive Disease (VOD) and Liver Toxicity after Busulfan/Cyclophosphamide Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Comparison between Anti-Thymocyte Globulin and Alemtuzumab and the Possible Impact of KIR-Ligand Mismatch in Melphalan/Fludarabine Dose-Reduced Conditioning Followed by HLA-Matched and Mismatched Unrelated Stem Cell Transplantation in Patients with Multiple Myeloma.

Kinetics of the Graft-Versus-Leukemia Response After Donor Leukocyte Infusions for Relapsed Chronic Myeloid Leukemia After Allogeneic Bone Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

Introduction of Differential KIR Activation Mediated Patters of NK Cell Cytotoxicity Against Myeloma

Donor KIR-Haplotype B Improved Relapse-Free Survival After Allogeneic Stem Cell Transplantation for Multiple Myeloma

Comparable Results of HLA-Mismatched Vs HLA-Matched Unrelated Donors for Allogeneic Stem Cell Transplantation Using Pre-Transplant ATG.

Donor KIR Haplotype Genes Significantly Influence Disease-Free and Overall Survival after Myeloablative Conditioning Followed by In Vivo T-Cell Depleted [ATG] Unrelated Stem Cell Transplantation.

MTHFR-A1298C Polymorphism Is Associated with Veno-Occlusive Disease (VOD) and Liver Toxicity after Busulfan/Cyclophosphamide Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation (HSCT).

Comparison between Anti-Thymocyte Globulin and Alemtuzumab and the Possible Impact of KIR-Ligand Mismatch in Melphalan/Fludarabine Dose-Reduced Conditioning Followed by HLA-Matched and Mismatched Unrelated Stem Cell Transplantation in Patients with Multiple Myeloma.

Kinetics of the Graft-Versus-Leukemia Response After Donor Leukocyte Infusions for Relapsed Chronic Myeloid Leukemia After Allogeneic Bone Marrow Transplantation

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only